Aeson TAH System - Post-Market Clinical Follow-up Study

NCT05474092 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2026-01-28

No results posted yet for this study

Summary

The safety and performance of the Aeson TAH system have been demonstrated for the CE mark approval in December 2020. The purpose of this post-market clinical investigation is to confirm the safety, performance and effectiveness of the Aeson TAH system when used in routine care by surgeons.

Conditions

Interventions

DEVICE

Aeson Total Artificial Heart

Heart Replacement Therapy

Sponsors & Collaborators

  • Carmat SAS

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-23
Primary Completion
2028-05-31
Completion
2030-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05474092 on ClinicalTrials.gov